In contrast with its role as an oncogene in glioma and osteosarcoma, miR-1908 may act as a tumor suppressor in liver cancer by targeting MARK1 (Microtubule affinity-regulating kinase 1) signaling pathway. Here, MARK1 is linked to glioma.